LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
NASHVILLE, Tenn. & LAKELAND, Fla.–(BUSINESS WIRE)–OrderInsite, an industry-leading technology platform for pharmacies to manage, monitor…
The latest offering through Hitachi Application Reliability Centers empowers data-driven leaders with trustworthy, secure and…
SAN FRANCISCO, June 01, 2023 (GLOBE NEWSWIRE) — Excision BioTherapeutics, Inc., a clinical-stage biotechnology company…
SAN FRANCISCO, June 01, 2023 (GLOBE NEWSWIRE) — Excision BioTherapeutics, Inc., a clinical-stage biotechnology company…
Seer’s Proteograph XT pushes the boundaries of biological discovery by enabling rapid proteomics across a…
Seer’s Proteograph XT pushes the boundaries of biological discovery by enabling rapid proteomics across a…
Carlsbad, CA, June 01, 2023 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”),…
Carlsbad, CA, June 01, 2023 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”),…
TORONTO, June 01, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia…
TORONTO, June 01, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia…
– YUSIMRY™ (adalimumab-aqvh) will be the first biologic product offered by the Mark Cuban Cost Plus…
– YUSIMRY™ (adalimumab-aqvh) will be the first biologic product offered by the Mark Cuban Cost Plus…
Seasoned sector leaders will advise Culture’s leadership in customer intelligence and innovation SAN FRANCISCO, June…
Seasoned sector leaders will advise Culture’s leadership in customer intelligence and innovation SAN FRANCISCO, June…
VANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
VANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
JUPITER, Fla., June 01, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…